Impact of diabetes on stage I lung cancer treatment patterns and prognosis in older adults: A population-based cohort study

[1]  Eunhee Ha,et al.  Association of type 2 diabetes mellitus with lung cancer in patients with chronic obstructive pulmonary disease , 2023, Frontiers in Medicine.

[2]  K. Hernandez-Villafuerte,et al.  Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany , 2023, Oncology research.

[3]  B. Shia,et al.  Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma , 2022, Cancers.

[4]  Jun Zhang,et al.  Targeting interleukin-1β and inflammation in lung cancer , 2022, Biomarker research.

[5]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[6]  B. Seal,et al.  Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. , 2021, JAMA oncology.

[7]  M. Ezzati,et al.  Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records , 2021, The lancet. Diabetes & endocrinology.

[8]  B. Stricker,et al.  The Obesity Paradox in Lung Cancer: Associations With Body Size Versus Body Shape , 2020, Frontiers in Oncology.

[9]  T. Okamoto,et al.  Analysis of Risk Factors for Bronchopleural Fistula after Surgical Treatment of Lung Cancer , 2020, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[10]  J. Leonard,et al.  Diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study , 2020, Cancer.

[11]  L. Xue,et al.  The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis , 2019, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[12]  J. Unger,et al.  Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation , 2019, JAMA oncology.

[13]  Xi Zheng,et al.  Diabetes mellitus and survival of non‐small cell lung cancer patients after surgery: A comprehensive systematic review and meta‐analysis , 2019, Thoracic cancer.

[14]  A. Nicholson,et al.  The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. , 2018, Quantitative imaging in medicine and surgery.

[15]  W. Willett,et al.  Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis , 2018, Journal of the National Cancer Institute.

[16]  J. I. Choi,et al.  Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes. , 2018, Translational lung cancer research.

[17]  M. Gould,et al.  Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer , 2017, Annals of the American Thoracic Society.

[18]  R. Decker,et al.  Stage I Lung SBRT Clinical Practice Patterns , 2017, American journal of clinical oncology.

[19]  D. Albanes,et al.  Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[20]  S. Jolly,et al.  Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Jason D. Wright,et al.  Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Isaac Subirana,et al.  Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis , 2016, Diabetes Care.

[23]  N. Staff,et al.  Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients , 2015, Journal of the Neurological Sciences.

[24]  John D. Mitchell,et al.  Prediction of major cardiovascular events after lung resection using a modified scoring system. , 2014, The Annals of thoracic surgery.

[25]  M. Grant,et al.  Inflammation in the pathogenesis of microvascular complications in diabetes , 2012, Front. Endocrin..

[26]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[27]  E. Halm,et al.  Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. , 2010, American journal of respiratory and critical care medicine.

[28]  W. Katon,et al.  Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. , 2008, The American journal of managed care.

[29]  J. Coebergh,et al.  Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis , 2007, International journal of cancer.

[30]  J. Geraci,et al.  Results of General Internal Medicine Consultations for Diabetes Mellitus in 283 Cancer Patients , 2007, The American journal of the medical sciences.

[31]  Edward L Spitznagel,et al.  Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Gregory S. Cooper,et al.  Studying Radiation Therapy Using SEER-Medicare-Linked Data , 2002, Medical care.

[33]  Beth A Virnig,et al.  Utility of the SEER-Medicare Data to Identify Chemotherapy Use , 2002, Medical care.

[34]  C. Klabunde,et al.  Overview of the SEER-Medicare Data , 2002 .

[35]  G. Cooper,et al.  Use of SEER-Medicare Data for Measuring Cancer Surgery , 2002, Medical care.

[36]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[37]  C. Coltman,et al.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.

[38]  B. Yawn,et al.  Identifying Persons with Diabetes Using Medicare Claims Data , 1999, American journal of medical quality : the official journal of the American College of Medical Quality.

[39]  M. Mack,et al.  Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. , 1997, The Journal of thoracic and cardiovascular surgery.

[40]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.